Continuous glucose monitors (CGMs) present a problem of lack of accuracy, especially in the lower range, sometimes leading to missed or false hypoglycemia. A new algorithm is presented here aimed at improving the measurement accuracy and hypoglycemia detection. Its core is the estimation of blood glucose (BG) in real time (RT) from CGM intensity readings using autoregressive (AR) models.
Methods:
Eighteen patients with type 1 diabetes were monitored for three days (one at the hospital and two at home) using the CGMS® Gold. For these patients, BG samples were taken every 15 min for 2 h after meals and every half hour otherwise during the first day. The relationship between the current measured by the CGMS Gold and BG was learned by an AR model, allowing its RT estimation. New capillary glucose measurements were used to correct the model BG estimations.
Results:
A total of 563 paired points were obtained from BG and monitor readings to validate the new algorithm. 98.5% of paired points fell in zones A+B of the Clarke error grid analysis with the proposed algorithm. The overall mean and median relative absolute differences (RADs) were 9.6% and 6.7%. Measurements meeting International Organization for Standardization (ISO) criteria were 88.7%. In the hypoglycemic range, the mean and median RADs were 8.1% and 6.0%, and measurements meeting ISO criteria were 86.7%. The sensitivity and specificity with respect to hypoglycemia detection were 91.5% and 95.0%.
Conclusions:
The performance measured with both clinical and numerical accuracy metrics illustrates the improved accuracy of the proposed algorithm compared with values presented in the literature. A significant improvement in hypoglycemia detection was also observed.
KovatchevBClarkeWL. Continuous glucose monitoring (CGM) reduces risks for hypo- and hyperglycemia and glucose variability in diabetes. Diabetes.2007;56 (Suppl 1): A23.
2.
KlonoffDC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care.2005;28 (5): 1231–9.
3.
DeissDBolinderJRivelineJ PBattelinoTBosiETubiana-RufiNKerrDPhillipM. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care.2006;29 (12): 2730–2.
4.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study GroupTamborlaneWVBeckRWBodeBWBuckinghamBChaseHPClemonsRFiallo-ScharerRFoxLAGilliamLKHirschIBHuangESKollmanCKowalskiAJLaffelLLawrenceJMLeeJMaurasNO'GradyMRuedyKJTanseyMTsalikianEWeinzimerSWilsonDMWolpertHWysockiTXingD. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med.2008;359 (14): 1464–76.
5.
EllisSLBookoutTGargSKIzuoraKE. Use of continuous glucose monitoring to improve diabetes mellitus management. Endocrinol Metab Clin North Am.2007;36Suppl 2: 46–68.
6.
KingCAndersonSMBretonMClarkeWLKovatchevBP. Modeling of calibration effectiveness and blood-to-interstitial glucose dynamics as potential confounders of the accuracy of continuous glucose sensors during hyperinsulinemic clamp. J Diabetes Sci Technol.2007;1 (3): 317–22.
7.
RebrinKSteilGMvan AntwerpW PMastrototaroJJ. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol.1999;277 (3 Pt 1): E561–71.
BretonMKovatchevBP. Analysis, modeling, and simulation of the accuracy of continuous glucose sensors. J Diabetes Sci Technol.2008;2 (5): 853–62.
10.
CengizETamborlaneW V. A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther.2009;11Suppl 1: S11–6.
11.
WeinzimerSADeLuciaMCBolandEASteffenATamborlaneWV. Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms. Diabetes Technol Ther.2003;5 (3): 375–80.
12.
BuckinghamB. Analysis: dawn of real-time continuous glucose sensing. Diabetes Technol Ther.2003;5 (3): 381–3.
13.
Diabetes Research In Children Network (Direcnet) Study GroupBuckinghamBAKollmanCBeckRKalajianAFiallo-ScharerRTanseyMJFoxLAWilsonDMWeinzimerSARuedyKJTamborlaneWV. Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther.2006;8 (3): 318–25.
14.
FacchinettiASparacinoGCobelliC. Reconstruction of glucose in plasma from interstitial fluid continuous glucose monitoring data: role of sensor calibration. J Diabetes Sci Technol.2007;1 (5): 617–23.
15.
LesperanceLMSpektorAMcLeodKJ. Calibration of the continuous glucose monitoring system for transient glucose monitoring. Diabetes Technol Ther.2007;9 (2): 183–90.
16.
Eren-OrukluMCinarAQuinnLSmithD. Estimation of future glucose concentrations with subject-specific recursive linear models. Diabetes Technol Ther.2009;11 (4): 243–53.
17.
FinanDAZisserHJovanovicLBevierWCSeborgDE. Practical issues in the identification of empirical models from simulated type 1 diabetes data. Diabetes Technol Ther.2007;9 (5): 438–50.
18.
SparacinoGZanderigoFCorazzaSMaranAFacchinettiACobelliC. Glucose concentration can be predicted ahead in time from continuous glucose monitoring sensor time-series. IEEE Trans Biomed Eng.2007;54 (5): 931–7.
19.
ReifmanJRajaramanSGribokAWardWK. Predictive monitoring for improved management of glucose levels. J Diabetes Sci Technol.2007;1 (4): 478–86.
20.
GaniAGribokAVRajaramanSWardWKReifmanJ. Predicting subcutaneous glucose concentration in humans: data-driven glucose modeling. IEEE Trans Biomed Eng.2009;56 (2): 246–54.
ClarkeWLCoxDGonder-FrederickLACarterWPohlSL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care.1987;10 (5): 622–8.
23.
ParkesJLSlatinSLPardoSGinsbergBH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care.2000;23 (8): 1143–8.
24.
Medtronic Minimed. The Medtronic Minimed CGMS® System SolutionsTM Software: User Guide MMT-7310, Version 3.0C. 2003.
25.
VellemanPFHoaglinDC. Applications, basics, and computing of exploratory data analysis. Boston: Duxbury Press; 1981.
26.
BondiaJTarínCGarcía-GabinWEsteveEFernández-RealJMRicartWVehíJ. Using support vector machines to detect therapeutically incorrect measurements by the MiniMed CGMS. J Diabetes Sci Technol.2008;2 (4): 622–9.
27.
WentholtIMVollebregtMAHartAAHoekstraJBDeVriesJH. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. Diabetes Care.2005;28 (12): 2871–6.
28.
GargSKSmithJBeatsonCLopez-BacaBVoelmleMGottliebPA. Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems. Diabetes Technol Ther.2009;11 (2): 65–72.
29.
LjungL. System identification: theory for the user. Englewood Cliffs: Prentice Hall; 1999.
30.
MATLAB. System identification Toolbox. Natick: The MathWorks, Inc.; 2007.
31.
WeinsteinRLSchwartzSLBrazgRLBuglerJRPeyserTAMcGarraughGV. Accuracy of the 5-day FreeStyle Navigator continuous glucose monitoring system: comparison with frequent laboratory reference measurements. Diabetes Care.2007;30 (5): 1125–30.
32.
MazzeRSStrockEBorgmanSWesleyDStoutPRacchiniJ. Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time?Diabetes Technol Ther.2009;11 (1): 11–8.
33.
KovatchevBAndersonSHeinemannLClarkeW. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care.2008;31 (6): 1160–4.
34.
KovatchevBPGonder-FrederickLACoxDJClarkeWL. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care.2004;27 (8): 1922–8.
35.
BodeBGrossKRikaloNSchwartzSWahlTPageCGrossTMastrototaroJ. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther.2004;6 (2): 105–13.
36.
GargSJovanovičL. Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care.2006;29 (12): 2644–9.
37.
GargSKVoelmleMKGottliebP. Feasibility of 10-day use of a continuous glucose-monitoring system in adults with type 1 diabetes. Diabetes Care.2009;32 (3): 436–8.
38.
International Organization for Standardization. In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197:2003. Geneva: International Organization for Standardization; 2003.
